AHN Allegheny General Hospital is a clinical research site located in Pittsburgh, Pennsylvania, United States 15212.
Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.
AHN Allegheny General Hospital has participated in 15 clinical trials with 10 currently active.
Therapeutic areas: Breast Cancer, Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a).
Sponsors: Eli Lilly and Company, Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute), Bristol-Myers Squibb.
Trust Score: 75/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
AHN Allegheny General Hospital has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
AHN Allegheny General Hospital has 15 clinical trials on record, with 10 currently active. Their work covers Breast Cancer, Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a).
AHN Allegheny General Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.